Mind Cure Health Inc.

DB:6MH Stock Report

Market Cap: €4.9m

Mind Cure Health Management

Management criteria checks 2/4

Mind Cure Health's CEO is Philip Tapley, appointed in Mar 2022, he has a tenure of less than a year. His total yearly compensation is CA$52.50K , comprised of 28.6% salary and 71.4% bonuses, including company stock and options. He directly owns 1.92% of the company’s shares, worth €94.05K. The average tenure of the management team and the board of directors is 1.1 years and 2.3 years respectively.

Key information

Philip Tapley

Chief executive officer

CA$52.5k

Total compensation

CEO salary percentage28.6%
CEO tenureless than a year
CEO ownership1.9%
Management average tenure1.1yrs
Board average tenure2.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Philip Tapley's remuneration changed compared to Mind Cure Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Nov 30 2022n/an/a

-CA$9m

Aug 31 2022n/an/a

-CA$12m

May 31 2022CA$53kCA$15k

-CA$14m

Feb 28 2022n/an/a

-CA$13m

Nov 30 2021n/an/a

-CA$13m

Aug 31 2021n/an/a

-CA$13m

May 31 2021CA$239kCA$120k

-CA$10m

Compensation vs Market: Philip's total compensation ($USD38.59K) is below average for companies of similar size in the German market ($USD442.77K).

Compensation vs Earnings: Philip's compensation has been consistent with company performance over the past year.

CEO

Philip Tapley

less than a year

Tenure

CA$52,500

Compensation

Mr. Philip Tapley serves as Chief Executive Officer at Mind Cure Health Inc. since October 1, 2022. Mr. Tapley is Founder of Mind Cure Health Inc and served as Interim Chief Executive Officer since March 1...

Leadership Team

NamePositionTenureCompensationOwnership
Philip Tapley
Founderless than a yearCA$52.50k1.92%
€ 94.1k
Michael Wolfe
Chief Financial Officer1.8yrsCA$252.74k0.085%
€ 4.2k
Tarik Lebbadi
Chief Operating Officer1.9yrsno datano data
Daniel Kim
Vice President of Investor Relationsno datano datano data
Daniel Herrera
Chief Growth Officerless than a yearno datano data
Doron Sagman
Chief Medical Officer1.2yrsno datano data
Clare Purvis
Chief Product Officerless than a yearno datano data

1.1yrs

Average Tenure

Experienced Management: 6MH's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Philip Tapley
Founder2.9yrsCA$52.50k1.92%
€ 94.1k
Jason Pamer
Independent Director2.8yrsCA$50.00k0.80%
€ 39.2k
Stephen Inouye
Directorless than a yearCA$121.42k0.47%
€ 23.0k
John Brownstein
Member of Advisory Board1.8yrsno datano data
Jason Wallach
Member of Scientific Advisory Board2.3yrsno datano data
Hamilton Morris
Member of Advisory Board2.3yrsno datano data
Ken Weingardt
Consulting Senior Clinical Technology Advisor1.5yrsno datano data
Joel Raskin
Member of Scientific Advisory Boardno datano datano data
Ty Tashiro
Member of Advisory Boardno datano datano data

2.3yrs

Average Tenure

Experienced Board: 6MH's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/02/26 09:55
End of Day Share Price 2022/11/29 00:00
Earnings2022/11/30
Annual Earnings2022/05/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mind Cure Health Inc. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution